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It has been established over the years that the capacity of an individual to form anti- 
bodies  to  almost  any  conceivable chemical  structure  is  extremely  diverse.  That  is, 
essentially  any  structural  entity  can  serve  as  an  antigenic  determinant  or  hapten. 
However, the "recognition" of a molecule as an immunogen is more restricted.  As one 
example,  poly-7-I)-glutamic  acid  (PGA) ~ of  average tool wt  35,000  cannot  elicit an 
immune response in pure form, but serves as a hapten when complexed to an immuno- 
genic carrier (1). Animals which have produced circulating antibody to PGA by virtue 
of  immunization  with  PGA-carrier  complexes do  not  exhibit  cellular immune  reac- 
tions,  such as delayed hypersensitivity in vivo or lymphocyte stimulation in cell cul- 
ture, when challenged with the pure polypeptide (2,  3), and it cannot serve as a carrier 
for a  conjugated azohapten in normal animals or in animals actively producing  anti- 
PGA antibody  (1).  Thus,  while there are apparently  antibody-forming cells (AFC or 
B  cell) for determinants  on PGA, which is a  multivalent hapten  on the basis  of pre- 
cipitation with antibody,  it is not recognized as an antigen unless introduced with a 
suitable carrier. This is true even when two different determinants are present (PGA- 
azohapten conjugates),  each of which is an effective hapten  (1). A requirement for at 
least two different determinants on a  molecule to confer immunogenicity has been re- 
ported (4). While this may be a necessary condition, it is not a sufficient one if neither 
of the determinants  fulfills the carrier function required for immunogenicity.  Similar 
examples have been described  (5). 
In recent years a need for at least two functionally distinct populations of immuno- 
cytes for the induction of humoral immunity has become recognized  (6-9).  The evi- 
dence suggests that one of these is an antigen-reactive cell (ARC or T  cell) which does 
not secrete antibody  but  does  interact with antigen,  presumably  via specific surface 
receptors.  This cell appears  to have come under  the influence of the thymus at some 
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point in its history and is needed for the initiation of cellular immune phenomena,  the 
elicitation of which distinguishes  immunogens from haptens.  Evidence for these rela- 
tionships  derives from human  disease (diGeorge's syndrome)  as well as from experi- 
mental work with animals. 
Consistent  with these findings is the supposition  that  nonimmunogenicity  of 
haptens  is  due  to  the  absence  of  a  structural  determinant  on  the  molecule 
which  can  interact  above  a  threshold  thermodynamic  level with  receptors  on 
one  or  more  clones  of  ARC.  It  follows  from  this  that  every  immunogenic 
molecule has  at  least  one such  determinant.  Using small,  structurally  defined 
immunogens,  it  should  be possible  to  dissect  the  immunogenic  or  recognition 
determinant(s)  from  haptenic  determinants  which  dictate  the  specificity  of 
serum  antibody.  This has  been accomplished using glucagon,  a  polypeptide  of 
29 amino acids.  A  brief report  of the earliest findings has been published  (10). 
Materials and Methods 
Antigen.--Crystalline bovine glucagon was a gift from Dr. W. Bromer. Additional quanti- 
ties were purchased from Mann Research Laboratories Inc., New York. The preparation of 
tryptic fragments of glucagon was carried out as described (11). An 0.085% solution of gluca- 
gon was incubated with 0.005%  trypsin  (1-tosylamide-2% phenylethyl-chloromethyl ketone 
[TPCK]-treated) in 0.05 ~ sodium citrate containing 1 mg/ml of CaC12 at  25°C, pH 7-8, for 
2.5 hr with gentle shaking. The digest was then adjusted to pH 3.0 with HC1, heated to 90°C for 
2 min, and lyophilized. The resulting three fragments (N, M, and C, Fig. 1) and free arginine 
were separable by high-voltage electrophoresis on paper (pH 3.5, 3000  v for 1 hr). They were 
initially identified by differential staining for arginine, tyrosine-histidine, and tryptophan, and 
their identity was later confirmed by amino acid analysis using a Beckman model 120 C ana- 
lyzer (Beckman Instruments, Inc., Fullerton, Calif.). 
The fragments were prepared by washing the lyophilized digest with 0.1 N acetic acid. The 
acid soluble fraction contained fragments N and M, which were resolved on Sephadex G-25. M 
was desalted by passage through Sephadex G-10. The acid insoluble precipitate was vacuum- 
dried and the C fragment was purified by preparatory high-voltage electrophoresis on paper at 
pH 3.5; it was eluted with 1 N ammonia. 
To obtain the NM fragment  (Fig. 1), lysine was blocked using citraconic anhydride  (2- 
methyl-maleic anhydride) as previously described for insulin (12). For every 15 mg of gluca- 
gon, 100 mg of citraconic anhydride was added and the mixture was stirred at room tempera- 
ture while maintaining the pH at 8.0 by addition of NaOH. Base uptake ceased after about 10 
min and the preparation was desalted by filtration through Sephadex G-25 in 0.5% NH4HCO3. 
Tryptic digestion of the blocked polypeptide was carried out as described above. To remove 
the blocking group, the lyophilized digest was acidified and left at room temperature overnight. 
The acid soluble fraction was chromatographed on Sephadex G-25 in 0.1 N acetic acid and the 
NM peptide was obtained in pure form. 
Animals and Immunization.--Randomly bred guinea pigs of both sexes weighing approxi- 
mately 600 g were immunized with 0.1-1.0 mg of glucagon emulsified in complete Freund's 
adjuvant and distributed among all four footpads. Animals were bled 2 wk later. 
Radloimmunoassay for Anti-Glucagon Antibody.--Glucagon was radiolabeled with 125I as 
described for the iodination of insulin (13). All glassware exposed to the isotope was siliconized. 
The iodinated product was purified by passage through Sephadex G-25 and had a specific ac- 
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To assay for antibody, a  dextran-coated charcoal radioimmunoassay described for insulin 
(14)  was adopted.  Coated charcoal was prepared  by mixing equal volumes of 5% charcoal 
(Decolorizing Carbon, Norit, Eastman organic Chemicals, Rochester, N.Y.) and 0.5% Dextran 
500 (Pharmacia Fine Chemicals, Piscataway, N.J.)  in 0.1 •  phosphate buffer, pH 7.4. Assays 
were performed in siliconized  glass tubes.  50 ~zl of  12~I-glucagon containing approximately 
2000 cpm were added to varying quantities of serum or 3'-globulin fractions of serum. Volumes 
were brought to 0.5 ml with 0.1 M phosphate buffer, pH 7.4, and the tubes were incubated at 
4°C for 1 hr. For assays of the inhibition of binding of radiolabeled glucagon, inhibitors were 
added to tubes containing a quantity of serum which bound 50-60% of the counts and incuba- 
tion at 4°C was extended to 18-24 hr. After incubation, the tubes were transferred into an ice 
bath and 0.3 ml of a  suspension of cold coated charcoal was added to each  tube. The tubes 
were mixed and  centrifuged for 10 min at 1500 rpm. A sample of each supernatant was trans- 
ferred into fresh tubes and the tubes were counted in a  Packard Auto-Gamma Spectrometer 
(Packard Instrument Company, Downers Grove, Ill.).  The fraction of total radioactivity in 
the superuatant was taken as the measure of glucagon bound by antibody. Assays with pre- 
immune sera established the baseline. In no instance did  such a  serum bind more than  5% of 
the radioactivity. 
Skin Tests.~40-10O/~g  of antigen in 0.1 ml of phosphate-buffered saline, pH 7.4, were in- 
jected intradermally into a shaved area of the fank. Reactions were recorded 2 and 24 hr after 
challenge. An area of induration 5 mm or larger 24 hr after challenge was considered a positive 
delayed hypersensitivity reaction. 
Capillary Migration of Peritoneal Exudate Cells (15).--Peritoneal  exudates were induced by 
intraperitoneal injection of 20 ml of light mineral oil. 3 days later the cells were harvested by 
washing the peritoneal cavity with 200 ml of Hanks' solution. Packed cells were suspended in 
Spinner's medium, 7.5% by volume, and capillary tubes were filled with the cell suspension. 
The tubes were sealed and centrifuged in the cold for 5 min at 900 rpm. They were cut at the 
cell-fluid interface and placed in Mackaness-type culture chambers, two tubes per chamber; 
chambers were prepared  in duplicate or  triplicate.  The chambers were filled with Spinner's 
medium containing 100 units of penicillin and 100 units of streptomycin/ml, 1% L-glutamine, 
15% normal guinea pig serum, and various concentrations of the test antigen. The chambers 
were then sealed and incubated for 24-48 hr at 37°C. Migration patterns were projected and 
traced,  and the areas were measured using a planimeter. The areas of migration in duplicate 
test chambers (four tubes) were averaged, and the results were expressed as per cent inhibition 
of migration in chambers containing antigen based Oll comparison with the migration of cells 
in chambers containing no antigen. 
Lymphocyte Stimulation  (16).--4-5  X  10  e  lymph node  cells were  culturered  in  2  ml  of 
Eagle's minimal essential medium containing 100 units each of penicillin and streptomycin/ml, 
1% L-glutamine, and 5% calf serum. Antigen was added in 0.1 ml of saline and the cultures 
were incubated at 37°C in an atmosphere of 5% CO 2 and 95% air for 2 days, at the end of which 
period  0.05  ~Ci  of  t4C-methyI-thymidine  (New  England  Nuclear  Corp.,  Boston,  Mass.; 
specific activity 24.5 mCi/mM) was added to each culture tube. After an additional 24 hr incu- 
bation, the cells were harvested in the cold by serially suspending them once in saline, twice in 
5% trichloroacetic acid, and once in absolute methanol. The dried residue was dissolved by in- 
cubation in 1 ml of hyamine at 56°C for 1 hr followed by 3-24 hr at 37°C, transferred to count- 
ing vials, and prepared for scintillation counting by addition of 12 ml of Omnifluor  (New Eng- 
land Nuclear Corp.) in toluene (4 g of Omnifluor in 1  liter toluene).  Radioactivity was meas- 
ured using a  Packard Tri-Carb liquid scintillation spectrometer.  The variation between repli- 
cate cultures seldom exceeded -t-5%. 
Peptide Synthesis.--A series of peptides corresponding to  the  amino-terminal portion  of 
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residue 16  (serine)  and  extended back to residue 2 (serine).  The peptides were assayed for 
their capacity to block the binding of radiolabeled glucagon by antiserum. A detailed account 
of their preparation, purification, and characterization has been published (18). 
Another series of peptides corresponding to the carboxy-terminal  sequence of glucagon were 
synthesized using a somewhat modified approach. The presence of tryptophan and methionine 
in this sequence necessitated the use of protective reagents such as anisoleand 1,2-ethane di- 
thiol to minimize oxidation during synthesis and in the final  cleavage of the product from the 
resin. Two side reactions were noted. After addition of aspartic acid, cyclization of the aspartyl 
residue occurred to s~me extent, as previously observed (19). A previously unreported rear- 
rangement, N to O acyl migration involving threonine was observed beginning at the dipeptide 
TABLE  I 
Amino Acid Analyses of Glucagon and Its Tryptic Fragments 
Glucagon  N M  C 
Amino acid  Expected  Found  Expected  Found  Expected  Found 
M/M*  M/M  M/M  M/M  M/M  M/M 
Lysine  1.00  1.00~:  1.00  1.00J~  0.00  0.01 
Histidine  1.00  0.91  1.00  0.95  0.00  0.01 
Arginine  2.00  2.29  1.00  1.18  0.00  0.77 
Aspar  tic acid  4.00  4.11  2.00  2.00  2.00  2.04 
Threonine  3.00  2.25  2.00  1.46  1.00  0.96 
Serine  4.00  3.68  4.00  3.95  0.00  0.00 
Glutamic acid  3.00  3.14  1.00  1.13  2.00  2.04 
Proline  0.00  0,00  0.00  0.00  0.00  0.00 
Glycine  1.00  0.86  1.00  1.00~/  0.00  0.00 
Alanine  1.00  1.09  0.00  0.00  1.00  1,00~ 
Half-cystine  0.00  0.00  0.00  0.00  0.00  0.00 
Valine  1.00  1.00:~  0.00  0.00  1.00  1.05 
Methionine  1.00  1.00  0.00  0.00  1.00  0.96 
Isoleucine  0.00  0.00  0.00  0.00  0.00  0.00 
Leucine  2.00  2.04  1.00  0.95  1.00  1.00 
Tyrosine  2.00  1.98  2.00  1.95  0.00  0.01 
Phenylalanine  2.00  2.09  1.00  1.00  1.00  0.96 
* M/M  =  moles per mole. 
Ratios normalized to this amino acid. 
stage. 2  The products became very poorly soluble after the pentapeptide stage precluding analy- 
sis for impurities by high-voltage electrophoresis. A number of purification techniques were 
attempted. The best results were obtained by repeated passage through Sephadex G-15  in 
1 n  NH4OH.  The purified products were characterized by amino acid analysis. They were 
assayed for capacity to stimulate lymphocytes  from glucagon-sensitized  anima]s. 
RESULTS 
Characterization  of  Peptides.--Amino  acid  analyses  of  glucagon  and  its 
purified  NM  and  C  tryptic  fragments  are  shown  in  Table  I.  By  analyzing 
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varying quantities of the fragments, it was established that they had a degree 
of purity of at least 99 %. Amino acids which would represent contamination 
by either intact glucagon or the complementary fragment were never found in 
significant quantity,  even when the columns were overloaded with the peptide 
hydrolysates. 
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FIG. 1.  The structure of glucagon and its fragments produced by digestion 
NH 2 
IIHIS 
24S/R 
3.J.GLN 
4.J.G L  Y 
5ITHR 
6{PHE 
7~THR 
8~.SER 
9~.ASP 
IO/TYR 
11 " 'SER 
12" 'LYS 
13"  TYR 
14" 'LEU 
15" 'ASP 
16" SER 
17" ARG 
18" ARG 
19"  ALA 
20" 'GLN 
21  ASP 
22  PHE 
23" VAL 
24" GLN 
25"  TRY 
26ILEU 
274MET 
28 J.ASN 
29JTHR 
COOH 
with trypsin. 
The C  fragment proved to be a mixture of undeca-  and dodecapeptides, due 
to incomplete cleavage of the  second of two consecutive arginine  residues  at 
position 18 (Fig. 1). This was established by recovery of less than the quantity 
of free arginine  expected on  the  basis  of complete cleavage,  and  by the  ap- 
pearance of arginine in fractional molar quantities in the analysis of C  (Table 
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Sephadex  G-15  in  1 N  ammonia.  Only the  second  peak  contained  arginine, 
indicating  that  resolution  was due  to adsorption  of the  larger peptide to  the 
gel. 
Specificity of Humoral Antibody.--All guinea pigs immunized with glucagon 
responded  with  humoral  antibody  detected  by  the  binding  of  12~I-glucagon. 
50 t~l of antiserum bound from 50 to 80% of the 2000  cpm used for each  assay, 
whereas preimmune sera consistently  bound  less than  5%.  The  tryptic frag- 
ments of glucagon inhibited this binding in the  order NM > C > N > M.  Curves 
for a  representative serum are shown in Fig. 2.  While the increments between 
the  ligands  varied from one  serum  to  another,  the  order  of effectiveness did 
not. M  peptide was totally ineffective in all assays, and the molar ratio C:NM 
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Fro. 2.  Inhibition of binding between 12aI-glucagon (2000 cpm) and serum from an im- 
mune guinea pig by unlabeled glucagon and its tryptic fragments. 
required for a  given level of inhibition was never less than 5:1  and frequently 
much greater. 
When the fragments were added in pairs to assess their combined inhibitory 
effect, it was found that the combination of N  and C  was additive, indicating 
that  the  two fragments reacted with distinct  antibody populations.  NM  and 
C  also produced an additive effect, raising the level of inhibition to that :given 
by intact  glucagon.  However,  since  in  some antisera  the  inhibition  given by 
NM  and  C  separately added  up  to  more  than  100%,  some overlap  appears 
likely. These results show that the antibodies produced in response to glueagon 
are heterogeneous in specificity, but the major antigenic determinant in all ani- 
mals tested is carried by the NM fragment (residues 1-17). 
The structural requirements of the antigenic determinant in NM for binding 
with  antibody  were  assessed  by  assaying  a  series  of  synthetic  peptides  for 
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caused  by arginine  (residue  17)  during synthesis.  The smallest peptide  with 
demonstrable  activity  was  a  dodecapeptide  encompassing  residues  5-16 of 
glucagon (Fig. 3). Larger peptides were somewhat more effective but did not 
yield a consistent gradient of increasing activity with size, and none proved as 
active as native NM.  It is of interest that X-ray diffraction studies indicate 
that  glucagon  is  about  75 %  helical,  with  two  sections of helix.  The model 
which best fits the data and permits the most stable placement of hydrophobic 
residues predicts a helical segment between residues 5-16 and another between 
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FIG. 3.  Inhibition of binding between 125I-glucagon  (2000 cpm) and serum from an im- 
mune guinea pig by native NM peptide and a series of synthetic peptides initiated at residue 
16. 
residues 17-28 (20). In conjunction with this model, the relative ineffectiveness 
of the N  peptide and the initial appearance of activity with synthetic peptide 
5-16 suggest that reactivity with antibody may depend strongly on the con- 
formation of the amino-terminal portion of glucagon. 
Specificity of Cellular Immunity.--Cellular immune activities of glucagon and 
its fragments were assayed by their ability to elicit delayed cutaneous hyper- 
sensitivity reactions, to inhibit capillary migration of peritoneal exudate cells, 
and to stimulate the synthesis of deoxyribonucleic acid (DNA) by lymphocytes 
in vitro. In addition, limited investigations of the immunogenicity of NM and 
C peptides were conducted. 
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glucagon and the fragments. All animals tested gave positive delayed reactions 
with  glucagon  and  C,  and  somewhat weaker  though  unambiguous  reactions 
with NM (Table II). N  was only marginally active, with 1 of 6 animals giving 
a  mildly positive reaction,  and M  was totally inactive.  None of the prepara- 
tions gave positive reactions when tested in normal guinea pigs, and none of 
the immune guinea pigs showed a positive reaction with any of the antigens 2 
hr after injection. 
(b) Inhibition of capillary  migration:  To confirm the results of delayed skin 
reactions,  inhibition  of migration of peritoneal cells from capillary tubes was 
performed. The results of the two tests correlated perfectly (Table II) Glu- 
cagon,  C,  and  NM,  at  concentrations  of 50-100  #g/ml  of culture  medium, 
TABLE II 
Cellular Immune Response of Guinea Pigs to Glucagon 
Test  Average delayed  Inhibition of 
antigen  skin reaction  cell migration* 
Lymphocyte 
stimulation:I 
Range  Mean 
mm  % 
Glucagon  14  (20)§  65  (8)  2.3-26.0  10.9  (13) 
n  3  (6)  21  (3) 
U  0  (6)  0  (3) 
NM  8  (6)  55  (3)  0.7-1.1  0.8  (6) 
C  12  (6)  75  (3)  2.7-20.0  8.8  (13) 
* The figures were derived from the following equation: 
1  migration of cells in chambers containing antigen~ 
migratio~ of cells in chambers withou-~-  antige~  |  ]  X  100 
:~ Ratio of 14C-thymidine incorporation in cultures with antigen present relative  to cul- 
tures without antigen from the same animal. 
§ Parentheses indicate number of animals tested. 
inhibited migration strongly, whereas N  exhibited only a mild inhibitory effect 
and M was again inactive. None of the preparations was inhibitory when tested 
with peritoneal cells from normal animals. 
(c)  Lymphocyte  stimulation  in  vitro:  Glucagon  and  C  were  highly  active 
and almost equivalent in their capacities to stimulate lymph node cells from 
immune animals to synthesize DNA (Tables II and III). But whereas glucagon 
and  C  stimulated  as much  as  26-fold and  20-fold respectively, NM  did  not 
stimulate significantly above background over the concentration range tested. 
This pattern was very consistent  (Table III). Moreover, with  cells from two 
animals which  were stimulated somewhat better by glucagon than by C, the 
addition of equimolar quantities of NM to C did not enhance its transforming 
activity (Table III). Sera from all these animals showed the pattern of speci- 1302  FUNCTIONAL  DISSECTION  OF  AN  ANTIGEN  MOLECULE 
TABLE  III 
In Vitro a4C-Thymidine Incorporation in Response to Glucagon Peptides in Lymph Node 
Cell Cultures Derived  from Glucagon-Sensitized Guinea Pigs 
Animal  Glucagon 
Maximum stimulation* given by 
NM  C  NM +  C 
(0.15-28.00) ~t  (0.25-50.00)  (3-33) 
1  15.0  16.0 
2  14.1  12.5 
3  12.0  8.6 
4  2.3  4.1 
5  17.8  18.0 
6  7.2  5.9 
7  11.0  9.2 
8  6.2  1.1  2.7 
9  26.0  1. I  20.0 
10  6.4  0.8  5.0 
11  13.2  1.1  4.4 
12  5.7  0.9  4.3 
13  4.4  0.7  3.4 
2.2 
20.0 
* Ratio of l*C-thymidine incorporation in cultures with antigen present relative  to  cul- 
tures without antigen from the same animal. 
~t Concentration range used, in millimicromoles per milliliter of culture medium. 
TABLE  IV 
Stimulation  of  Lymph  Node Cell Cultures from  Glucagon-Sensitlzed Animals  by 
Natural and Synthetic Peptides 
Maximum stimulation* given by 
Animal  Synthetic peptides 
Glucagon  C  Cfi~  C~  dodeca  undeca  deca 
1  12.0  8.6  6.8  1.6  3.5 
2  15.0  16.0  1.0  9.0 
3  14.0  12.5  3.8  3.8 
4  17.8  18.0  2.1 
5  11.0  9.2  7.1  1.1  1.1 
6  15.0  12.7  10.2  10.5  4.3  4.3 
1.0 
1.3 
1.8 
* Ratio of a4C-thymidine incorporation in cultures with antigen present relative to cultures 
without antigen from the same animal. 
:~ Natural carboxY-terminal undecapeptide of glucagon. 
§ Natural carboxy-terminal dodecapeptide of glucagon. 
ficity described  earlier.  NM  was  always  a  much  more  effective inhibitor than 
C  of the binding of radiolabeled glucagon by antiserum. 
Synthetic  peptides  simulating  the  C  fragment  confirmed  the  transforming 
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peptides had to be extensively purified by repeated passage through Sephadex 
G-15 because of a toxic effect on lymphoid cells,  possibly due to residual traces 
of anisole and 1,2-ethane dithiol in the preparations. Even the purest prepara- 
tions were less active than native C, despite amino acid analytical data in good 
agreement  with  theoretical  ratios  (Table  V).  Peptides  smaller  than  the  un- 
decapeptide were inactive with cells which were strongly stimulated by native 
C  as  well  as  by  the  synthetic  undecapeptide.  Surprisingly,  the  synthetic 
dodecapeptide was also much less active than the undecapeptide in all save one 
instance. This was confirmed by assaying the undeca-  and dodecapeptides of 
native C, which were resolved by passage through Sephadex G-15. The fraction 
which  analyzed for arginine  and is therefore the dodecapeptide is designated 
TABLE V 
Amino Acid Analyses of Synthetic Carboxy-Terminal Peptides of Glucagon 
Amino acid* 
Undecapeptide  Dodecapeptide 
Expected  Found  Expected  Found 
M/M~  M/M  M/M  M/M 
Aspartic acid  2.00  2.16  2.00  2.13 
Threonine  1.00  1.07  1.00  1.03 
Glutamic acid  2.00  I. 87  2.00  1.74 
Alanine  1.00  0.99  1.00  0.97 
Valine  1.00  0.98  I. 00  0.92 
Methionine  1.00  0.94  1.00  0.92 
Leucine  1.00  1.00§  1.00  1.00§ 
Phenylalanine  1.00  0.98  1.00  0.93 
* Tryptophan and  nitroarginine  are  not  incIuded because 
during hydrolysis. 
:~ M/M  =  moles per mole. 
§ Ratios  normalized to  this  amino acid. 
they  are largely destroyed 
C2  in Table IV;  the  arginine-less  undecapeptide  is  designated  C1.  It can  be 
seen  that  the  relative effectiveness of C1  and  C~ correlated with  that of the 
synthetic  peptides  and  varied  from  one  animal  to  another.  The  variation 
ranged  from  one  individual  in  which  Ct  stimulated  16-fold,  while  C~  was 
virtually  inactive,  to  another  in  which  the  two  were  indistinguishable.  The 
addition  of arginine,  which  is the  only basic residue  in  this sequence,  to the 
undecapeptide  drastically  reduced  its  transforming  activity  in  most  cases, 
despite the presence of arginine at that position in the native sequence. None 
of the native or synthetic peptides had a stimulatory effect on cells from normal 
animals. 
Immunogenicity of NM  and C Peptides.--Three  guinea pigs in  each group 
were immunized with 0.4 mg of natural NM or C  in complete Freund's adju- 
vant, distributed equally between the four footpads. They were bled and skin 1304  FUNCTIONAL  DISSECTION  OF  AN  ANTIGEN  MOLECULE 
tested during the 3rd wk after immunization.  Using glucagon as the antigen, 
this regimen invariably results in skin sensitization and circulating antibody. 
None of these animals gave delayed hypersensitivity skin reactions when tested 
with up to 100 #g of glucagon and the peptides used for immunization, nor could 
glucagon-binding antibodies be demonstrated in any of the sera. Thus, neither 
of the peptides, if immunogenic at all, is as strongly immunogenic as the parent 
molecule. 
DISCUSSION 
The central finding of this study is a striking dissociation in virtually all the 
guinea pigs assayed between the specificity of circulating anti-glucagon antibody 
and the specificity of immunocytes which are transformed by antigen in culture. 
The amino-terminal heptadecapeptide (NM) was a far more effective inhibitor 
of the binding of glucagon by antibody than was the carboxy-terminal undeca- 
or dodecapeptide (C).  On the other hand,  NM  was  totally unable to trigger 
lymphoid cells to synthesize DNA, whereas C was almost as active, if not as 
active, as intact glucagon in  this  capacity. Although  amino acid analyses of 
NM  and C  indicated a  very high degree of purity, the inherent transforming 
activity of C was unambiguously substantiated with synthetic peptides. 
The use  of synthetic C  peptides demonstrated that  residue  19,  alanine,  is 
essential for transforming activity, since the carboxy-terminal decapeptide was 
inactive  whereas  the  undecapeptide  was  highly  active.  However,  it  is  not 
known how much of the sequence carboxy-terminal to residue  19 is required 
for this activity. A very stringent structural requirement for cellular stimula- 
tion was indicated by the finding that  the natural  and synthetic dodecapep- 
tides  were markedly  less  active  than  their undecapeptide counterparts  with 
cells from most of the animals tested. Nevertheless, the pattern of reactivity 
varied from animal to animal, and cells from one guinea pig did not distinguish 
between the undeca- and dodecapeptides (Table V). This kind of variation is 
not unlike that seen in  the specificities of populations of antibody molecules 
from different animals. The loss of activity in the dodecapeptide could be due 
to the charge introduced by arginine,  the only basic residue in the sequence, 
or to an altered conformation of the peptide. It would be of interest to determine 
at which point activity is recovered upon lengthening the peptide; restoration 
must  occur since  the parent  molecule is  fully active.  Studies  to  answer  this 
question are in progress. 
These findings are very easily reconciled with the now widely accepted two- 
cell mechanism of immune induction (6-9). The antigen-reactive cell, or T  cell, 
must  recognize a  molecule in  order for it to be immunogenic.  Subsequently, 
there is an as yet undefined interaction between the T  cell and an antibody- 
producing cell precursor, or B cell, presumably but not necessarily through the 
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into a mature antibody-producing cell. Although interaction between the cells 
and antigen appears to be specific, the parts of an antigen molecule with which 
the two cells interact may be mutually exclusive. In the case of glucagon, we 
propose that the major immunogenic or recognition determinant for T  cells is 
carried by the C peptide, whereas the major haptenic determinant for B  cells 
is carried by the NM fragment. Obviously, this distinction need not be absolute. 
The antibodies produced against glucagon are heterogeneous in specificity and 
a  minor population  in  a  considerable  fraction  of the  animals  tested  showed 
specificity for the C  peptide.  Similarly, there may be T  cells with specificity 
for an amino-terminal determinant  of glucagon, but they may go undetected 
either because the assay method is too insensitive or because they do not react 
with the NM fragment. It does not appear likely that such a population of T 
cells could be substantial, since C and glucagon showed very similar stimulatory 
activities with cells from most of the animals (Table III). 
The immunogenic determinant of a molecule can be regarded as fulfilling the 
carrier function  of a  hapten-carrier  conjugate  and  might be expected to be 
immunogenic itself, at least to the extent of provoking cellular immunity. The 
limited  experimental  testing  of  the  immunogenicity  of  the  tryptic  peptides 
reported here was negative, indicating that C  is at best a weaker immunogen 
than glucagon. However, more extensive tests over a broader dosage range of 
antigen will be necessary before firm conclusions can be drawn. 
Several  investigators  have  demonstrated  a  correlation  between  delayed 
cutaneous hypersensitivity and inhibition  of migration of cells from capillary 
tubes  (15,  21-23).  The  findings  with  glucagon  peptides  are  consistent  with 
those  of others inasmuch  as each peptide which  elicited  a  skin reaction  also 
inhibited  cell  migration,  and  their  effectiveness in  the  two  assays showed  a 
roughly quantitative correlation (Table II). However, we failed to find a cor- 
relation between skin reactivity or inhibitory capacity on the one hand,  and 
the ability to transform cells in vitro on the other, since the NM peptide was 
decidedly active in  the  two former assays but  exerted  no palpable  effect on 
DNA synthesis  (Table III). This contrasts with several reports (21,  24),  but 
is in agreement with others which demonstrated a  dissociation between these 
activities  (23,  25).  It is unclear  whether  the activities represent different ex- 
pressions by the same cells or expressions by different populations of cells.  In 
either case, a particular ligand could conceivably trigger the release of migra- 
tion  inhibitory factor without  activating DNA synthesis.  To our knowledge, 
there are no known instances of the reverse, antigen-specific cell stimulation in 
the absence of in vivo or in vitro delayed hypersensitivity. 
SUMMARY 
Bovine glucagon, a polypeptide of 29 amino acids, was immunogenic in guinea 
pigs.  The  immunologic  determinants  of  glucagon  were  investigated  using 1306  FUNCTIONAL DISSECTION  OF  AN  ANTIGEN  MOLECULE 
isolated tryptic peptides of the hormone. Antibodies from virtually all of more 
than  two  dozen  animals  had  specificity  primarily  for  the  amino-terminal 
heptadecapeptide  (NM)  and  showed  little  or  no  binding  with  the  carboxy- 
terminal undeca- and dodecapeptides (C). The smallest synthetic peptide of a 
series  initiated  at  residue  16  which  measurably  bound  antibody  comprised 
residues 5-16 of glucagon. 
In cellular immune assays, both NM and C elicited delayed cutaneous reac- 
tions  and  inhibited  the  migration  of peritoneal  cells  from immune  animals. 
However, only intact glucagon and its C  fragment stimulated lymphoid cells 
to synthesize DNA.  While  glucagon was somewhat more active than  C,  the 
addition of NM  to C did not  enhance its transforming activity. The smallest 
synthetic carboxy-terminal peptide with discernible transforming activity com- 
prised  residues  19-29  of glucagon.  In  both  native  and  synthetic  C  peptide 
preparations, the undecapeptide was generally more active than the dodecapep- 
tide,  although  cells  from different  animals  gave different  response patterns. 
The difference between the two is the presence of arginine at the amino-terminus 
of the peptide chain. Thus, the recognition specificity of populations of antigen- 
reactive cells from different animals displays a variation which is at least super- 
ficially analogous to that of populations of antibody molecules. 
In limited experiments using NM  and  C  peptides  as immunogens,  neither 
gave rise to delayed hypersensitivity or to glucagon-binding circulating anti- 
body,  following  a  regimen  which  invariably provoked these  responses  when 
glucagon itself served as the immunogen. 
These results indicate that glucagon was cleaved by trypsin along functional 
lines into two parts, one of which housed the major antigenic determinant and 
the other of which carried the major immunogenic determinant,  and they are 
highly  compatible with  a  two-cell mechanism  of immune induction.  An  ap- 
parent dissociation between the capacity to provoke delayed hypersensitivity 
reactions and to transform antigen-reactive cells in culture was observed. 
We gratefully acknowledge the advice and assistance of Drs. Lynn Spider, E. Benjamini, 
G. G. B. Klaus, and G. Windridge with various technical procedures. 
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